KLRK1 and B-cell chronic lymphocytic leukemia: This is an interesting finding, as NKG2D expression was impaired in the CLL patients compared to the HDs at baseline while NKp30 expression was not, suggesting that compensation among different NK receptors can take place in order to restore the impaired NK function.